Rivals Fight Myriad Bid For Gene Test Ban In Patent Case

Law360, New York (August 15, 2013, 7:41 PM ET) -- Two companies sued by Myriad Genetics Inc. over genetic testing patents asked a Utah federal judge Wednesday not to impose a preliminary injunction on their competing tests, arguing that Myriad's case is based on a misreading of a recent U.S. Supreme Court ruling on different Myriad patents.

Ambry Genetics Corp. and Gene By Gene Ltd., who were sued by Myriad within days of each other in July, filed a joint opposition to Myriad's injunction motion which said their tests for detecting an increased risk of breast...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers